We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Non-Invasive Process Determines Blood Glucose Levels Without Sample

By LabMedica International staff writers
Posted on 03 Oct 2022
Print article
Image: New non-invasive blood glucose monitoring process could put an end to painful pricks to draw blood (Photo courtesy of Pexels)
Image: New non-invasive blood glucose monitoring process could put an end to painful pricks to draw blood (Photo courtesy of Pexels)

Diabetics are often required to prick their finger several times a day to draw blood and check their glucose levels using an electronic monitor. Researchers have been working on working on improving the glucose monitoring process for the millions of people around the world affected by diabetes by making it less invasive and painful. Now, a team of researchers has created a non-invasive process that can identify the exact value of blood glucose with 90% accuracy without taking a blood sample.

The GlucoCheck process developed by researchers at Kennesaw State University (Kennesaw, GA, USA) uses light shone through human tissue, in either the ear or finger, and a small camera to capture images on the other side. The team then uses a model to study the amount of light absorption in those images to determine blood glucose concentration. The team has filed a provisional patent application with the U.S. Patent and Trademark Office to protect the process they have created. The researchers have tested the process on nearly 50 people so far, but before filing a full patent next summer, they will assess how the process works on people with a range of skin pigmentations and skin thickness. The team has already created a mobile phone application and is working on connecting GlucoCheck to Amazon’s virtual assistant, Alexa.

“Our pilot study was very successful. We are excited about how this device will help people with diabetes, which affects about one in every 10 people in the United States,” said Maria Valero, assistant professor of information technology in Kennesaw State’s College of Computing and Software Engineering (CCSE). “The way we gather and output the data is novel, and we will continue to work on ways to improve the glucose estimation model.”

Related Links:
Kennesaw State University 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.